Spesolimab: New Standard of Care for Generalized Pustular Psoriasis Flare Treatment

https://pubmed.ncbi.nlm.nih.gov/38114719

Spesolimab, a drug targeting IL-36 receptor, demonstrates effectiveness in treating generalized pustular psoriasis flares, establishing a new standard of care in this field.